Market Capitalization of Concord Drugs (CONCORD)
As of Sept. 18, 2026, Concord Drugs (CONCORD) market capitalisation is ₹105.37 Cr ($11.71M), with 1.40 Cr shares outstanding at a current price of ₹75.30 on BSE, ranking 3111 out of 5367 companies by market cap in our screener. Concord Drugs operates in the Healthcare sector and is classified as a Small Cap stock. View CONCORD price range for the annual high/low range and current price position.
Market Cap History of Concord Drugs (Last 10 Years)
CONCORD market capitalisation from year-end BSE closing prices over the last 10 years. For live price, earnings and the complete company profile, see Concord Drugs share price today.
End of Year Market Cap History — Concord Drugs
CONCORD year-end market cap in INR and USD with closing share price and annual change — BSE closing prices. Explore CONCORD Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹105.37 Cr
$11.71M USD
|
₹75.30 | BSE | -8.71% |
| 2025 |
₹115.42 Cr
$12.82M USD
|
₹82.48 | BSE | +118.78% |
| 2024 |
₹52.75 Cr
$5.86M USD
|
₹37.70 | BSE | -36.87% |
| 2023 |
₹83.57 Cr
$9.29M USD
|
₹59.72 | BSE | +83.47% |
| 2022 |
₹45.55 Cr
$5.06M USD
|
₹32.55 | BSE | +1.24% |
| 2021 |
₹44.99 Cr
$5.00M USD
|
₹32.15 | BSE | +40.39% |
| 2020 |
₹32.04 Cr
$3.56M USD
|
₹22.90 | BSE | +52.67% |
| 2019 |
₹20.99 Cr
$2.33M USD
|
₹15.00 | BSE | -33.63% |
| 2018 |
₹31.62 Cr
$3.51M USD
|
₹22.60 | BSE | -29.37% |
| 2017 |
₹44.78 Cr
$4.98M USD
|
₹32.00 | BSE | -34.69% |
| 2016 |
₹68.57 Cr
$7.62M USD
|
₹49.00 | BSE | -17.72% |
| 2015 |
₹83.33 Cr
$9.26M USD
|
₹59.55 | BSE | - |